| Market Capitalization (Millions $) |
213 |
| Shares
Outstanding (Millions) |
83 |
| Employees |
226 |
| Revenues (TTM) (Millions $) |
76 |
| Net Income (TTM) (Millions $) |
15 |
| Cash Flow (TTM) (Millions $) |
22 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Protalix Biotherapeutics Inc. is a biopharmaceutical company based in Israel. It specializes in the development and commercialization of recombinant therapeutic proteins for the treatment of various diseases. The company focuses on utilizing its proprietary plant cell-based protein expression system, ProCellEx®, to produce a wide range of protein-based therapeutics.
Protalix's ProCellEx technology offers advantages over traditional production methods, as it enables the efficient production of complex proteins with enhanced stability and bioactivity. This innovative platform has been used to develop and manufacture several FDA-approved products, including Elelyso® (taliglucerase alfa) for the treatment of Gaucher disease.
The company's pipeline includes other promising product candidates targeting different medical conditions, such as Fabry disease, cystic fibrosis, and immune-mediated disorders. Protalix also collaborates with other pharmaceutical companies and researchers to broaden its therapeutic capabilities and explore new applications for its technology.
In addition to its focus on product development, Protalix Biotherapeutics places great emphasis on ensuring patients' access to its treatments. The company actively engages in reimbursement negotiations and collaborations with healthcare providers to facilitate widespread availability and affordability of its therapies.
Overall, Protalix Biotherapeutics Inc. is a biopharmaceutical company that utilizes its ProCellEx technology to develop and commercialize recombinant therapeutic proteins, with the ultimate goal of improving patients' lives by addressing various medical needs.
Company Address: 2 University Plaza Hackensack 7601 NJ
Company Phone Number: 696-9345 Stock Exchange / Ticker: NYSEAMER PLX
|
3.88% 
100 %